Cargando…
Direct costs of carcinoid syndrome diarrhea among adults in the United States
BACKGROUND: The burden of carcinoid syndrome (CS) among patients with neuroendocrine tumors is substantial and has been shown to result in increased healthcare resource use and costs. The incremental burden of CS diarrhea (CSD) is less well understood, particularly among working age adults who make...
Autores principales: | Dasari, Arvind, Joish, Vijay N, Perez-Olle, Raul, Dharba, Samyukta, Balaji, Kavitha, Halperin, Daniel M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6931008/ https://www.ncbi.nlm.nih.gov/pubmed/31885426 http://dx.doi.org/10.3748/wjg.v25.i47.6857 |
Ejemplares similares
-
TELEPRO: Patient‐Reported Carcinoid Syndrome Symptom Improvement Following Initiation of Telotristat Ethyl in the Real World
por: Strosberg, Jonathan, et al.
Publicado: (2019) -
Management of Diarrhea in Patients With Carcinoid Syndrome
por: Naraev, Boris G., et al.
Publicado: (2019) -
Origin, Evolution, and Genotyping of Emergent Porcine Epidemic Diarrhea Virus Strains in the United States
por: Huang, Yao-Wei, et al.
Publicado: (2013) -
Efficacy of Detoxsan(®) powder on diarrhea caused by gastrointestinal neuroendocrine tumors
por: Langbein, Thomas, et al.
Publicado: (2019) -
Mycophenolate mofetil increases the risk of diarrhea in allogeneic hematopoietic stem cell transplantation recipients
por: Lin, Liangmo, et al.
Publicado: (2023)